Once PD-L1/PD-1 signaling is inhibited, the T-cells can respond to the inflammatory cytokines described previously to perform their anti-tumor function (Fig. 3) (Akinleye and Rasool 2019). This evidence concerns the gene CD274 and neoplasm.